[Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
Ruiz Manzano
J
J
Monreal
M
M
D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007263:Infusions, Parenteral; D007279:Injections, Subcutaneous; D015201:Meta-Analysis as Topic; D015337:Multicenter Studies as Topic; D011655:Pulmonary Embolism / Q000188:drug therapy / Q000517:prevention & control; D012008:Recurrence; D013923:Thromboembolism / Q000188:drug therapy*; D013997:Time Factors; D020246:Venous Thrombosis / Q000188:drug therapy*
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin